Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Chronic Heart Failure

Free Subscription 18.03.2019 1 Am J Cardiol 1 Basic Res Cardiol 1 Cardiovasc Res 1 Circ Arrhythm Electrophysiol 1 Circ Heart Fail 3 Circulation 1 Clin Cardiol 2 Eur J Heart Fail 11 Int J Cardiol 1 J Am Coll Cardiol 5 J Card Fail 1 J Cardiovasc Pharmacol 3 Lancet 2 N Engl J Med 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Cardiol

1. PATEL RB, Vaduganathan M, Felker GM, Butler J, et al
   Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial).
   Am J Cardiol. 2019 Feb 23. pii: S0002-9149(19)30230.
   PubMed     Text format     Abstract available
   
   

   
   Basic Res Cardiol

2. CAO T, Fan S, Zheng D, Wang G, et al
   Increased calpain-1 in mitochondria induces dilated heart failure in mice: role of mitochondrial superoxide anion.
   Basic Res Cardiol. 2019;114:17.
   PubMed     Text format     Abstract available
   
   

   
   Cardiovasc Res

3. ESFANDIARY A, Kutsche H, Schreckenberg R, Weber M, et al
   Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing.
   Cardiovasc Res. 2019 Mar 8. pii: 5372345. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Circ Arrhythm Electrophysiol

4. ELMING MB, Hammer-Hansen S, Voges I, Nyktari E, et al
   Right Ventricular Dysfunction and the Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
   Circ Arrhythm Electrophysiol. 2019;12:e007022.
   PubMed     Text format     Abstract available
   
   

   
   Circ Heart Fail

5. KRISTENSEN SL, Mogensen UM, Jhund PS, Rorth R, et al
   N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status.
   Circ Heart Fail. 2019;12:e005766.
   PubMed     Text format     Abstract available
   
   

   
   Circulation

6. SAVARESE G, Sattar N, Januzzi J, Verma S, et al
   Empagliflozin Is Associated With a Lower Risk of Post-Acute Heart Failure Rehospitalization and Mortality.
   Circulation. 2019;139:1458-1460.
   PubMed     Text format    
   
   
7. KUMAR AA, Kelly DP, Chirinos JA
   Mitochondrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
   Circulation. 2019;139:1435-1450.
   PubMed     Text format     Abstract available
   
   
8. COLLINS SP, Pang PS
   ACUTE Heart Failure Risk Stratification.
   Circulation. 2019;139:1157-1161.
   PubMed     Text format    
   
   

   
   Clin Cardiol

9. LI S, Zhang C, Liu N, Bai H, et al
   Titin-truncating Variants Are Associated with Heart Failure Events in Patients with Left Ventricular Noncompaction Cardiomyopathy.
   Clin Cardiol. 2019 Mar 9. doi: 10.1002/clc.23172.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Heart Fail

10. IKONOMIDIS I, Aboyans V, Blacher J, Brodmann M, et al
    The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascula
    Eur J Heart Fail. 2019 Mar 12. doi: 10.1002/ejhf.1436.
    PubMed     Text format     Abstract available
    
    
11. ESCOBAR C, Manzano L
    Mineralocorticoid receptor antagonists and acute heart failure.
    Eur J Heart Fail. 2019 Mar 12. doi: 10.1002/ejhf.1453.
    PubMed     Text format    
    
    

    
    Int J Cardiol

12. SCHMEISSER A, Rauwolf T, Ghanem A, Groscheck T, et al
    Right heart function interacts with left ventricular remodeling after CRT: A pressure volume loop study.
    Int J Cardiol. 2018;268:156-161.
    PubMed     Text format     Abstract available
    
    
13. COGSWELL R, Duval S, John R
    Left ventricular assist device is protective against cardiac transplant delisting for medical unsuitability.
    Int J Cardiol. 2018 May 9. pii: S0167-5273(17)36080.
    PubMed     Text format     Abstract available
    
    
14. MAGUNIA H, Dietrich C, Langer HF, Schibilsky D, et al
    3D echocardiography derived right ventricular function is associated with right ventricular failure and mid-term survival after left ventricular assist device implantation.
    Int J Cardiol. 2018;272:348-355.
    PubMed     Text format     Abstract available
    
    
15. KOCKOVA R, Sedlacek K, Wichterle D, Sikula V, et al
    Cardiac resynchronization therapy guided by cardiac magnetic resonance imaging: A prospective, single-centre randomized study (CMR-CRT).
    Int J Cardiol. 2018;270:325-330.
    PubMed     Text format     Abstract available
    
    
16. DOSHI R, Patel H, Shah P
    Pulmonary artery catheterization use and mortality in hospitalizations with HFrEF and HFpEF: A nationally representative trend analysis from 2005 to 2014.
    Int J Cardiol. 2018;269:289-291.
    PubMed     Text format     Abstract available
    
    
17. MAGRI D, Agostoni P, Sinagra G, Re F, et al
    Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2018;271:125-131.
    PubMed     Text format     Abstract available
    
    
18. WEIGAND S, Karl M, Brkic A, Lennerz C, et al
    The impact of multipole pacing on left ventricular function in patients with cardiac resynchronization therapy - A real-time three-dimensional echocardiography approach.
    Int J Cardiol. 2018;272:238-243.
    PubMed     Text format     Abstract available
    
    
19. HE X, Zeng H, Roman RJ, Chen JX, et al
    Inhibition of prolyl hydroxylases alters cell metabolism and reverses pre-existing diastolic dysfunction in mice.
    Int J Cardiol. 2018;272:281-287.
    PubMed     Text format     Abstract available
    
    
20. BROBERG CS, Valente AM, Huang J, Burchill LJ, et al
    Myocardial fibrosis and its relation to adverse outcome in transposition of the great arteries with a systemic right ventricle.
    Int J Cardiol. 2018;271:60-65.
    PubMed     Text format     Abstract available
    
    
21. KLEBER M, Kozhuharov N, Sabti Z, Glatz B, et al
    Relative hypochromia and mortality in acute heart failure.
    Int J Cardiol. 2019 Feb 27. pii: S0167-5273(18)35414.
    PubMed     Text format     Abstract available
    
    
22. TANG Y, Wu Y
    Decreased ATP production during mitochondrial calcium uniporter inhibition enhances autophagy and mitophagy to provide cardioprotection in cardiac failure.
    Int J Cardiol. 2019;282:67.
    PubMed     Text format    
    
    

    
    J Am Coll Cardiol

23. FELDMAN AM
    Precision Medicine for Heart Failure: Back to the Future.
    J Am Coll Cardiol. 2019;73:1185-1188.
    PubMed     Text format    
    
    

    
    J Card Fail

24. VERDONSCHOT JAJ, Cooper LT, Heymans SRB
    Parvovirus B19 in Dilated Cardiomyopathy: There Is More Than Meets the Eye.
    J Card Fail. 2019;25:64-66.
    PubMed     Text format    
    
    
25. HERNANDEZ GA, Lemor A, Blumer V, Rueda CA, et al
    Trends in Utilization and Outcomes of Pulmonary Artery Catheterization in Heart Failure With and Without Cardiogenic Shock.
    J Card Fail. 2019 Mar 8. pii: S1071-9164(18)31126.
    PubMed     Text format     Abstract available
    
    
26. MILLAR PJ, Notarius CF, Haruki N, Floras JS, et al
    Heart failure-specific relationship between muscle sympathetic nerve activity and aortic wave reflection.
    J Card Fail. 2019 Mar 9. pii: S1071-9164(18)31291.
    PubMed     Text format     Abstract available
    
    
27. GIUSEPPE GD, Chu A, Tu JV, Shanmugasegaram S, et al
    Incidence of Heart Failure Among Immigrants to Ontario, Canada: A CANHEART Immigrant Study.
    J Card Fail. 2019 Mar 12. pii: S1071-9164(18)30351.
    PubMed     Text format     Abstract available
    
    
28. VEST AR, Chan M, Deswal A, Givertz MM, et al
    Nutrition, Obesity and Cachexia in Patients with Heart Failure: A Consensus Statement from the HFSA Scientific Statements Committee.
    J Card Fail. 2019 Mar 12. pii: S1071-9164(18)30917.
    PubMed     Text format     Abstract available
    
    

    
    J Cardiovasc Pharmacol

29. PINTO G, Tondi L, Gemma M, De Marco A, et al
    Real Life Indications to Sacubitril/Valsartan Treatment in Patients with Chronic Systolic Heart Failure.
    J Cardiovasc Pharmacol. 2019 Mar 6. doi: 10.1097/FJC.0000000000000665.
    PubMed     Text format     Abstract available
    
    

    
    Lancet

30. BAX JJ, Di Carli M, Narula J, Delgado V, et al
    Multimodality imaging in ischaemic heart failure.
    Lancet. 2019;393:1056-1070.
    PubMed     Text format     Abstract available
    
    
31. NORMAND C, Kaye DM, Povsic TJ, Dickstein K, et al
    Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology.
    Lancet. 2019;393:1045-1055.
    PubMed     Text format     Abstract available
    
    
32. ROSSIGNOL P, Hernandez AF, Solomon SD, Zannad F, et al
    Heart failure drug treatment.
    Lancet. 2019;393:1034-1044.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

33. OH J, Kang SM
    Rivaroxaban in Patients with Heart Failure.
    N Engl J Med. 2019;380:988.
    PubMed     Text format    
    
    
34. ZANNAD F, Greenberg B, Fu M
    Rivaroxaban in Patients with Heart Failure. Reply.
    N Engl J Med. 2019;380:988-989.
    PubMed     Text format    
    
    

    
    Proc Natl Acad Sci U S A

35. HU J, Gao C, Wei C, Xue Y, et al
    RBFox2-miR-34a-Jph2 axis contributes to cardiac decompensation during heart failure.
    Proc Natl Acad Sci U S A. 2019 Mar 13. pii: 1822176116.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: